newsfilter
← Latest News
GlobeNewswire·

Osmotica Pharmaceuticals plc Reports Second Quarter 2020 Results and Provides Business Updates

Second quarter 2020 total revenue of $37.5 million Received U.S Food and Drug Administration (“FDA”) approval for Upneeq™ (oxymetazoline hydrochloride ophthalmic solution), 0.1% for acquired...